1.84 -0.14 (-7.07%)

56.19% Fall from 52W High

139.6K XNAS Volume

XNAS 04 Apr, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for Inhibikase Therapeutics Inc is scheduled for today, for the purpose of Inhibikase Therapeutics Inc Fourth Quarter Earnings Result for 2024 See details


Insider Trading disclosures for Inhibikase Therapeutics Inc

The latest disclosure was made by Mark T. Iwicki in Inhibikase Therapeutics Inc where a trade of 602,346 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 21, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mark T. Iwicki Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 602,346 602,346 - - Stock Option (Right to Buy)
Vincent E. Aurentz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 134,427 134,427 - - Stock Option (Right to Buy)
Christopher Cabell President & Head of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 1,100,705 1,100,705 - - Stock Option (Right to Buy)
Mark T. Iwicki Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 4,373,857 4,373,857 - - Stock Option (Right to Buy)
Mark T. Iwicki Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 1,794,291 1,794,291 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 39,620 39,620 - - Stock Option (Right to Buy)
Roberto Bellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 73,580 73,580 - - Stock Option (Right to Buy)
Roberto Bellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 116,585 116,585 - - Stock Option (Right to Buy)
Amit D. Munshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 56,600 56,600 - - Stock Option (Right to Buy)
Amit D. Munshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 116,585 116,585 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 22,640 22,640 - - Stock Option (Right to Buy)
Arvind Kush Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 116,585 116,585 - - Stock Option (Right to Buy)
Arvind Kush Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 56,600 56,600 - - Stock Option (Right to Buy)
David Canner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 22,640 22,640 - - Stock Option (Right to Buy)
David Canner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 116,585 116,585 - - Stock Option (Right to Buy)
Dennis N. Berman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 21,854 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 30,000 30,000 - - Stock Option (Right to Buy)
Dennis N. Berman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 30,000 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 6,667 6,667 - - Stock Option (Right to Buy)
Dennis N. Berman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 6,667 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 6,667 6,667 - - Stock Option (Right to Buy)
Dennis N. Berman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 6,667 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 3,780 3,780 - - Stock Option (Right to Buy)
Dennis N. Berman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 3,780 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 1,138 1,138 - - Stock Option (Right to Buy)
Dennis N. Berman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 1,138 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 21,854 21,854 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 45,000 45,000 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 3,643 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 3,643 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 3,643 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 3,643 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 3,643 3,643 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 16,667 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 16,667 16,667 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 20,834 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 20,834 20,834 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 35,000 0 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 35,000 35,000 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 21 Jan 2025 45,000 0 - - Stock Option (Right to Buy)
Roy Freeman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 3,780 0 - - Stock Option (Right to Buy)
Roy Freeman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 6,667 0 - - Stock Option (Right to Buy)
Roy Freeman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 6,667 0 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 6,667 6,667 - - Stock Option (Right to Buy)
Roy Freeman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 21,854 0 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 21,854 21,854 - - Stock Option (Right to Buy)
Roy Freeman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 1,138 0 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 1,138 1,138 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 3,780 3,780 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 30,000 30,000 - - Stock Option (Right to Buy)
Roy Freeman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 30,000 0 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 6,667 6,667 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 90,000 0 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 90,000 90,000 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 5,834 5,834 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 21 Jan 2025 5,834 0 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 30,000 30,000 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 6,667 6,667 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 6,667 6,667 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 3,780 3,780 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2025 21,854 21,854 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 344,452 344,452 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 172,191 172,191 - - Stock Option (Right to Buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 316,647 316,647 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 03 Jan 2025 4,059,744 4,059,744 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 03 Jan 2025 2,207,671 2,207,671 - - Stock Option (Right to Buy)
Milton H. Werner Director, President and CEO 03 Jan 2025 5,315,056 5,315,056 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 344,452 344,452 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 172,191 172,191 - - Stock Option (Right to Buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 316,647 316,647 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 432,853 432,853 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 235,383 235,383 - - Stock Option (Right to Buy)
Garth Lees-Rolfe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 470,861 470,861 - - Stock Option (Right to Buy)
Roberto Bellini Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 60,000 60,000 - - Stock Option (right to buy)
Roberto Bellini Director Purchase of securities on an exchange or from another person at price $ 1.37 per share. 21 Oct 2024 1,460,000 1,460,000 - 1.4 2,000,200 Common Stock
Amit D. Munshi Director Purchase of securities on an exchange or from another person at price $ 1.37 per share. 21 Oct 2024 365,000 365,000 - 1.4 500,050 Common Stock
Amit D. Munshi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 60,000 60,000 - - Stock Option (right to buy)
Arvind Kush Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 60,000 60,000 - - Stock Option (right to buy)
Arvind Kush Director Purchase of securities on an exchange or from another person at price $ 1.37 per share. 21 Oct 2024 145,000 145,000 - 1.4 198,650 Common Stock
David Canner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 60,000 60,000 - - Stock Option (right to buy)
N. Dennis Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2024 30,000 30,000 - - Stock Option (right to buy)
Gisele Dion Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2024 30,000 30,000 - - Stock Option (right to buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2024 30,000 30,000 - - Stock Option (right to buy)
Paul C. Grint Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jul 2024 30,000 30,000 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 01 Apr 2024 45,000 45,000 - - Stock Option (right to buy)
Garth Lees-Rolfe Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 90,000 90,000 - - Stock Option (right to buy)
Paul C. Grint Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 6,667 6,667 - - Stock Option (right to buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 6,667 6,667 - - Stock Option (right to buy)
Gisele Dion Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 6,667 6,667 - - Stock Option (right to buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 6,667 6,667 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 01 Mar 2023 210,000 210,000 - - Stock Option (right to buy)
Joseph Frattaroli Cheif Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 90,000 90,000 - - Stock Option (right to buy)
Gisele Dion Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 60,000 60,000 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 16 Aug 2022 5,000 5,335,433 - 0.8 4,000 Common Stock
Paul C. Grint Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Elizabeth G. O’Farrell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2022 40,000 40,000 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 27 May 2022 5,000 5,330,433 - 1.0 4,880 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 20 May 2022 10,000 5,325,433 - 0.6 6,000 Common Stock
Joseph Frattaroli Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.64 per share. 19 May 2022 3,948 48,091 - 0.6 2,543 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 07 Mar 2022 125,000 125,000 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 07 Mar 2022 125,000 125,000 - - Stock Option (right to buy)
Joseph Frattaroli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2022 62,500 62,500 - - Stock Option (right to buy)
Joseph Frattaroli Cheif Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2022 62,500 62,500 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 03 Jan 2022 21,853 5,315,433 - 2.0 44,143 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 03 Jan 2022 21,853 0 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Nov 2021 400 23,589 - 1.9 772 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Nov 2021 1,334 23,589 - 1.9 2,588 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Nov 2021 3,186 23,589 - 2.0 6,245 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Nov 2021 1,100 23,589 - 2.0 2,167 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Nov 2021 17,569 23,589 - 2.0 34,787 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Aug 2021 21,853 5,293,580 - 2.0 44,143 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 17 Aug 2021 21,853 0 - - Stock Option (right to buy)
Paul C. Grint Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 22,677 22,677 - - Stock Option (right to buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 22,677 22,677 - - Stock Option (right to buy)
Elizabeth G. O’Farrell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 22,677 22,677 - - Stock Option (right to buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 22,677 22,677 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 14 May 2021 16,918 5,271,727 - 4.6 77,654 Common Stock
Milton H. Werner Director, President and CEO, Ten Percent Owner 14 May 2021 43,707 0 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 14 May 2021 43,707 5,288,645 - 0.4 16,609 Common Stock
Paul C. Grint Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 6,825 6,825 - - Stock Option (right to buy)
Dennis N. Berman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 6,825 6,825 - - Stock Option (right to buy)
Elizabeth G. O’Farrell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 6,825 6,825 - - Stock Option (right to buy)
Milton H. Werner Director, President and CEO, Ten Percent Owner 22 Dec 2020 100,000 100,000 - - Stock Option (right to buy)
Joseph Frattaroli Chief Financial Officer 22 Dec 2020 44,143 44,143 - 10 441,430 Common Stock
Joseph Frattaroli Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 100,000 100,000 - - Stock Option (right to buy)
Roy Freeman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2020 6,825 6,825 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures